Incyte Corp (INCY)
75.64
-0.11
(-0.15%)
USD |
NASDAQ |
Nov 05, 09:34
Incyte Market Cap: 14.57B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 14.59B |
| November 01, 2024 | 14.67B |
| October 31, 2024 | 14.28B |
| October 30, 2024 | 14.24B |
| October 29, 2024 | 14.18B |
| October 28, 2024 | 12.66B |
| October 25, 2024 | 12.54B |
| October 24, 2024 | 12.57B |
| October 23, 2024 | 12.56B |
| October 22, 2024 | 12.64B |
| October 21, 2024 | 12.58B |
| October 18, 2024 | 12.80B |
| October 17, 2024 | 12.81B |
| October 16, 2024 | 12.76B |
| October 15, 2024 | 12.78B |
| October 14, 2024 | 12.62B |
| October 11, 2024 | 12.75B |
| October 10, 2024 | 12.60B |
| October 09, 2024 | 12.68B |
| October 08, 2024 | 12.67B |
| October 07, 2024 | 12.68B |
| October 04, 2024 | 13.01B |
| October 03, 2024 | 12.93B |
| October 02, 2024 | 13.04B |
| October 01, 2024 | 13.12B |
| Date | Value |
|---|---|
| September 30, 2024 | 12.74B |
| September 27, 2024 | 12.68B |
| September 26, 2024 | 12.54B |
| September 25, 2024 | 12.18B |
| September 24, 2024 | 12.27B |
| September 23, 2024 | 12.35B |
| September 20, 2024 | 12.66B |
| September 19, 2024 | 12.87B |
| September 18, 2024 | 12.55B |
| September 17, 2024 | 12.79B |
| September 16, 2024 | 12.79B |
| September 13, 2024 | 12.24B |
| September 12, 2024 | 12.20B |
| September 11, 2024 | 12.16B |
| September 10, 2024 | 12.16B |
| September 09, 2024 | 11.99B |
| September 06, 2024 | 11.80B |
| September 05, 2024 | 12.13B |
| September 04, 2024 | 12.39B |
| September 03, 2024 | 12.77B |
| August 30, 2024 | 12.65B |
| August 29, 2024 | 12.69B |
| August 28, 2024 | 12.64B |
| August 27, 2024 | 12.64B |
| August 26, 2024 | 12.55B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.98B
Minimum
Jul 05 2024
23.92B
Maximum
Jul 20 2020
16.34B
Average
16.46B
Median
Jan 11 2022
Market Cap Benchmarks
| Syndax Pharmaceuticals Inc | 1.632B |
| Merck & Co Inc | 255.91B |
| Pfizer Inc | 156.49B |
| Biomarin Pharmaceutical Inc | 12.54B |
| Allogene Therapeutics Inc | 614.79M |
Market Cap Related Metrics
| PE Ratio | 540.29 |
| PS Ratio | 4.026 |
| Price to Book Value | 4.595 |
| Price to Free Cash Flow | 976.54 |
| Price | 75.64 |
| Earnings Yield | 0.19% |
| Operating PE Ratio | 2701.31 |